Skip to content

CBA

HealthTech·France·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns CBA?

CBA is a French HealthTech company, now owned by Vivalto Partners and Amundi, Omnes Capital and 1 other, which acquired it in 2023 from Five Arrows Managers.

Verto is still listed as an investor in CBA, status not confirmed after the 2023 sale.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Verto
Most recent investor
Verto
Verto Growth I · 2020 · Growth
4 ownership periods · full history below

Key facts

HQFrance
SectorHealthTech
Key takeaways
  • ·Co-held by Verto, SOFIPACA - Groupe Crédit Agricole and Omnes Capital since 2019.
  • ·4 distinct PE sponsors across ownership cycles.

Ownership history

4 ownership periods · co-invest detected

Active
Co-invest · 4 holders · 2018 · present
Five Arrows Managers
2018 · 2023(5yr) · Five Arrows Principal Investments · 2024 · Growth

Five Arrows Managers sold CBA to Vivalto Partners and Amundi in 2023 after 5 years.

Verto
VertoActive
2019 · present(7yr) · Verto Growth I · 2020 · Growth
SOFIPACA - Groupe Crédit Agricole
2023 · present(3yr) · SOFIPACA Evergreen · 1991 · Growth
Omnes Capital
2024 · present(2yr) · Omnes Co-Investment · 2008 · Buyout

Questions

Who owns CBA?

CBA is now owned by Vivalto Partners and Amundi, Omnes Capital and 1 other, which acquired it in 2023 from Five Arrows Managers. Verto is still listed as an investor in CBA, status not confirmed after the 2023 sale.

When did Vivalto Partners and Amundi and 2 others acquire CBA?

Vivalto Partners and Amundi and 2 others acquired CBA in 2023, buying from Five Arrows Managers.

Who did CBA sell to?

Five Arrows Managers sold CBA to Vivalto Partners and Amundi in 2023 (Secondary).

Who has owned CBA over time?

CBA has been through 4 private-equity ownership periods: Five Arrows Managers · via Five Arrows Principal Investments · 2018–2023 · sold to Vivalto Partners and Amundi · (Secondary); Verto · via Verto Growth I · since 2019; SOFIPACA - Groupe Crédit Agricole · via SOFIPACA Evergreen · since 2023; Omnes Capital · via Omnes Co-Investment · since 2024.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue